Sunset view of a bridge in Tampa illuminated with purple lights for the 10th Annual Meeting of IACS-NAS 2023.
Aging, heart failure, regeneration, and cardiovascular medicine—explore research from the 10th Annual IACS-NAS Meeting now in CJPP 🫀▶️ https://ow.ly/ULFN50XqNAJ
#CardiovascularResearch #HeartHealth #IACSNAS2023
Sunset view of a bridge in Tampa illuminated with purple lights for the 10th Annual Meeting of IACS-NAS 2023.
Aging, heart failure, regeneration, and cardiovascular medicine—explore research from the 10th Annual IACS-NAS Meeting now in Canadian Journal of Physiology and Pharmacology 🫀▶️ https://ow.ly/iz6z50XqNGp
#CardiovascularResearch #HeartHealth #IACSNAS2023
Sunset view of a bridge in Tampa illuminated with purple lights for the 10th Annual Meeting of IACS-NAS 2023.
What’s next for cardiovascular medicine? Explore the research from #IACSNAS2023 featured in this Canadian Journal of Physiology and Pharmacology collection for insight into how researchers are advancing the science of #HeartHealth.
🫀▶️ https://ow.ly/HnE850XqO0G
Sunset view of a bridge in Tampa illuminated with purple lights for the 10th Annual Meeting of IACS-NAS 2023.
What’s next for cardiovascular medicine? Explore the research from #IACSNAS2023 featured in this Canadian Journal of Physiology and Pharmacology collection for insight into how researchers are advancing the science of heart health.
🫀▶️ https://ow.ly/Hf1R50XqNQ1
#CardiovascularResearch #HeartHealth
Effects of NAD+/NADH levels in disease pathophysiology and aging. An imbalance in the NAD+/NADH ratio generates reactive oxygen species, alters circadian rhythm, energy metabolism, inflammatory response and genome stability, and causes chronic metabolic diseases, cardiovascular and neurodegenerative diseases, aging, and cancer. NAD+, oxidized form of nicotinamide adenine dinucleotide; NADH, reduced form of nicotinamide adenine dinucleotide; ATP, adenosine triphosphate; and ROS, reactive oxygen species.
📰 Nampt: a new therapeutic target for modulating NAD+ levels in metabolic, cardiovascular, and neurodegenerative diseases
Read the full paper in this #IACSNAS2023 collection ▶️ https://ow.ly/YMbR50XqO7H
📸 cjpp-2024-0400_fig1 #CardiovascularResearch #HeartHealth
Effects of NAD+/NADH levels in disease pathophysiology and aging. An imbalance in the NAD+/NADH ratio generates reactive oxygen species, alters circadian rhythm, energy metabolism, inflammatory response and genome stability, and causes chronic metabolic diseases, cardiovascular and neurodegenerative diseases, aging, and cancer. NAD+, oxidized form of nicotinamide adenine dinucleotide; NADH, reduced form of nicotinamide adenine dinucleotide; ATP, adenosine triphosphate; and ROS, reactive oxygen species.
📰 Nampt: a new therapeutic target for modulating NAD+ levels in metabolic, cardiovascular, and neurodegenerative diseases
Read the full paper in this Canadian Journal of Physiology and Pharmacology collection ▶️ https://ow.ly/Yvqq50XqOeJ
📸 cjpp-2024-0400_fig1 #IACSNAS2023
Sunset view of a bridge in Tampa illuminated with purple lights for the 10th Annual Meeting of IACS-NAS 2023.
📰 Epigenetic regulation by ketone bodies in cardiac diseases and repair
Read the full paper in this #IACSNAS2023 collection ▶️ https://ow.ly/lR5a50XqO3V
Sunset view of a bridge in Tampa illuminated with purple lights for the 10th Annual Meeting of IACS-NAS 2023.
Researchers from around the world gathered at the 10th Annual Meeting of IACS-NAS in 2023 to explore new directions in cardiovascular medicine. Read their work in our new collection 🫀▶️ https://ow.ly/klzt50XqNyc
#CardiovascularResearch #HeartHealth #IACSNAS2023
Sunset view of a bridge in Tampa illuminated with purple lights for the 10th Annual Meeting of IACS-NAS 2023.
Cardiovascular researchers from around the world came together in 2023 to explore new directions in cardiovascular medicine. Read their work in this new Canadian Journal of Physiology and Pharmacology collection 🫀▶️ https://ow.ly/BVZW50XqNlW
#HeartHealth #IACSNAS2023
